Navigation Links
BioMarin Announces Buy Back of Naglazyme Royalties From Adelaide Health Authority
Date:11/30/2011

ioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase III clinical development for the treatment of MPS IVA, amifampridine phosphate (3,4-diaminopyridine phosphate), which is currently in Phase III clinical development for the treatment of LEMS in the U.S., PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU, BMN 701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase (IGF2-GAA), which is currently in Phase I/II clinical development for the treatment of Pompe disease, and BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor, which is currently in Phase I/II clinical development for the treatment of genetically-defined cancers. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Forward-Looking StatementThis press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the expectations of revenue and sales related to Naglazyme; the financial performance of the BioMarin as a whole; the continued clinical development and commercialization of Naglazyme; and actions by regulatory authorities. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among o
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
2. BioMarin Announces FDA Approval of Expanded Biologics Manufacturing Facility
3. BioMarin to Host a Research and Development Day on December 8th
4. BioMarin Announces Third Quarter 2011 Financial Results
5. BioMarin to Present at the UBS Global Life Sciences Conference
6. BioMarin to Present at the Morgan Stanley Global Healthcare Conference
7. BioMarin to Present at the Baird Health Care Conference
8. BioMarin to Present at the Wedbush Life Sciences Conference
9. BioMarin Announces Second Quarter 2011 Financial Results
10. BioMarin to Host Second Quarter 2011 Financial Results Conference Call and Webcast on Thursday, July 28 at 5:00 p.m. ET
11. BioMarin Agrees to Acquire Biologics Manufacturing Plant in Ireland from Pfizer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Annual Meeting of StockholdersWhen:Tuesday, June 30 at 5:10 p.m. ... Internet.  Simply log onto our website listed above.   ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. ...
(Date:6/29/2015)... June 30, 2015 , Gerresheimer will ... Corning and Gerresheimer enter into a 10-year-supply agreement for ... EUR 196m debt-free Corning and Gerresheimer ... pharmaceutical glass packaging market Gerresheimer,s outlook for the ... future disposal of the tubing business , In ...
(Date:6/29/2015)... 2015  Nevro Corp. (NYSE: NVRO ), a ... solutions for the treatment of chronic pain, today announced ... Officer of Intersect ENT (NASDAQ: XENT ), has ... 28, 2015. For the last seven ... ENT, a company dedicated to improving the quality of ...
Breaking Medicine Technology:Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 3Nevro Appoints Lisa Earnhardt to its Board of Directors 2
... WASHINGTON, Oct. 19, 2011 Sharon Ladin, director ... Project, issued the following statement regarding the bipartisan, ... today by Sen. Richard Blumenthal (D-Conn.) and Sen. ... to H.R. 2182 and contains provisions to incentivize ...
... The maker of MidNite ® Sleep ... formula, has succeeded in protecting the brand against patent ... president, Holly Rosenthal. Under the terms of the agreement ... Sleep Remedy, and Contract Pharmacal (CPC), a contract manufacturer ...
Cached Medicine Technology:Popular Sleep Supplement Brand Settles Patent Infringement Suit Against Store Brand Manufacturer 2
(Date:6/30/2015)... ... 2015 , ... Rocky Mountain Oils, a leading non-MLM supplier of premium ... new CEO, Mr. Darold Francis. The changes will help enhance the company’s focus on ... have come to know and respect for over eight years. , “I am thrilled ...
(Date:6/30/2015)... ... June 30, 2015 , ... The U.S. Women's National Soccer Team will face the Costa ... will be on Sunday, August 16th at Heinz Field in Pittsburgh at 1:30 p.m. local ... Finley Stadium in Chattanooga, TN. , The USA WNT previously played at Heinz Field in ...
(Date:6/30/2015)... Winston-Salem, NC (PRWEB) , ... June 30, 2015 , ... ... Northern Virginia” title in a recent online poll at http://scoutology.com/novaburgerwars and was ... issue to be published in August 2015. , Red Hot & Blue President Randy ...
(Date:6/30/2015)... ... 30, 2015 , ... Independence Day weekend is more than just fireworks to ... off of July as National Hot Dog Month. Americans are expected to eat more ... of the year and enough to stretch from Washington D.C. to Los Angeles more ...
(Date:6/30/2015)... ... June 30, 2015 , ... Board ... ENT and Allergy Center . , Dr. Antunes is a ... sinus and ear procedures. In addition to performing cosmetic and reconstructive surgery on ...
Breaking Medicine News(10 mins):Health News:Rocky Mountain Oils Adds New CEO, Announces Relocation of Operations to Orem, Utah 2Health News:USA vs. Costa Rica Tickets at Heinz Field in Pittsburgh and Finley Stadium in Chattanooga: Ticket Down Slashes Presale Ticket Prices for Costa Rica vs. USA WNT 2Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 2Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 3Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 2Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 3
... Richard Branson has received a mixed and varied response in ... community,// others opined that it may not be as beneficial ... placenta and umbilical cord is called cord blood. This can ... newborn baby is separated from the umbilical cord. This blood ...
... have a high proportion of viral strains that can use ... a study published in the February 15th edition of Clinical ... J Wilkin of Weill-Cornell Medical College, New York, also found ... as dual-tropic virus) had lower CD4 cell counts than people ...
... latest survey conducted in the United States, binge eating is ... 3.5 % binge eaters are// women while it is 2% ... by James Hudson and Harrison Pope Jr. and their team ... eaters have absolutely no control on their massive food intake. ...
... game helped obese children to maintain their weight. This game also ... to cardiac problems and// diabetes. ,In West Virginia, a ... group of 7-12 for a period of six months. Children chosen ... ‘Dance Dance Revolution’ at home for 30 minutes a day for ...
... otherwise calm, had suddenly turned awry. Guards in the ... the prisoner had been consuming from a gallon of ... ,The alarm regarding abuse of hand sanitizers was not ... Center, Dr. Suzanne Doyon, who has sought to raise ...
... Sarawak state of Borneo have been asked to close for a ... scare, state officials said. ,Denying any major ... ‘Let me stress this, it is not an outbreak as we ... nature, we want to prevent it from spreading. As of today, ...
Cached Medicine News:Health News:Mixed HIV Coreceptor Use Associated With Lower CD4 Count 2Health News:Mixed HIV Coreceptor Use Associated With Lower CD4 Count 3Health News:Mixed HIV Coreceptor Use Associated With Lower CD4 Count 4
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Medicine Products: